StockData
Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. (DYN) stock

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$15.87−0.15 (-0.94%)

Close on Nov 18, 2026Market cap $2.96BP/E –Yield –

Dyne Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Dyne Therapeutics

Dyne Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Dyne Therapeutics figures

See a number that looks wrong?